Atlas Trials

Clinical Trial of BCD-148 and Soliris® for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria

Clinical trial NCT04060264 · COMPLETED

Trial details

NCT number
NCT04060264
Sponsor
Biocad
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Paroxysmal Nocturnal Hemoglobinuria
Start date
2019-04-04
Primary completion
2020-04-27
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.